Luo, Y., Gordon, J. K., Xu, J., Kolstad, K. D., Chung, L., Steen, V. D., Bernstein, E. J., Csuka, M. E., Derk, C. T., Domsic, R. T., Fischer, A., Frech, T., Goldberg, A. Z., Hant, F., Hinchcliff, M., Horn, E., Hummers, L., Hsu, V., … Simms, R. (2023). Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry. Rheumatology, 63(5), 1251–1258. https://doi.org/10.1093/rheumatology/kead368

Bernstein, E. J., Denton, C. P., Huang, S., & Khanna, D. (2024). Baseline absolute monocyte count predicts lung function decline among patients with systemic sclerosis-associated interstitial lung disease: A post hoc analysis from the focuSSced trial. Seminars in Arthritis and Rheumatism, 65, 152376. https://doi.org/10.1016/j.semarthrit.2024.152376

Rahaghi, F. F., Hsu, V. M., Kaner, R. J., Mayes, M. D., Rosas, I. O., Saggar, R., Steen, V. D., Strek, M. E., Bernstein, E. J., Bhatt, N., Castelino, F. V., Chung, L., Domsic, R. T., Flaherty, K. R., Gupta, N., Kahaleh, B., Martinez, F. J., Morrow, L. E., Moua, T., … Khanna, D. (2023). Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respiratory Research, 24(1). https://doi.org/10.1186/s12931-022-02292-3

Simpson, C. E., Ambade, A. S., Harlan, R., Roux, A., Aja, S., Graham, D., Shah, A. A., Hummers, L. K., Hemnes, A. R., Leopold, J. A., Horn, E. M., Berman-Rosenzweig, E. S., Grunig, G., Aldred, M. A., Barnard, J., Comhair, S. A. A., Tang, W. H. W., Griffiths, M., … Rischard, F. (2023). Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology, 325(5), L617–L627. https://doi.org/10.1152/ajplung.00177.2023

Luebker, S., Frech, T. M., Assassi, S., Skaug, B., Gordon, J. K., Lakin, K., Bernstein, E. J., Luo, Y., Steen, V. D., Shah, A. A., Hummers, L. K., Richardson, C., Moore, D. F., Khanna, D., Castelino, F. V., Chung, L., Kapoor, P., Hant, F. N., Shanmugam, V. K., … Sandorfi, N. (2023). CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization. Rheumatology, 62(10), 3433–3438. https://doi.org/10.1093/rheumatology/kead176

Luebker, S., Frech, T. M., Assassi, S., Gordon, J. K., Bernstein, E. J., Steen, V. D., Shah, A. A., Hummers, L. K., Richardson, C., Khanna, D., Castelino, F., Chung, L., Hant, F. N., Shanmugam, V. K., VanBuren, J. M., Alvey, J., Harding, M., & Sandorfi, N. (2022). The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation. Clinical and Experimental Rheumatology. https://doi.org/10.55563/clinexprheumatol/04rauu

Roofeh, D., Brown, K. K., Kazerooni, E. A., Tashkin, D., Assassi, S., Martinez, F., Wells, A. U., Raghu, G., Denton, C. P., Chung, L., Hoffmann-Vold, A.-M., Distler, O., Johannson, K. A., Allanore, Y., Matteson, E. L., Kawano-Dourado, L., Pauling, J. D., Seibold, J. R., Volkmann, E. R., … Khanna, D. (2022). Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease. Rheumatology, 62(5), 1877–1886. https://doi.org/10.1093/rheumatology/keac557

Song, P., Li, S., Lewis, M. A., Fiorentino, D. F., & Chung, L. (2023). Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis. JAMA Dermatology, 159(3), 308. https://doi.org/10.1001/jamadermatol.2022.6330

Bruni, C., Chung, L., Hoffmann-Vold, A. M., Assassi, S., Gabrielli, A., Khanna, D., Bernstein, E. J., & Distler, O. (2021). High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey. Clinical and Experimental Rheumatology. https://doi.org/10.55563/clinexprheumatol/7ry6zz